Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Granisetron Transdermal Patch

A transdermal system containing granisetron, a selective serotonin (5-HT) receptor antagonist, with antiemetic activity. Upon application of the… Expand
National Institutes of Health

Related topics

Related topics

1 relation
Granisetron

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Observational Case Series Evaluation of the Granisetron Transdermal Patch System (Sancuso) for the Management of Nausea/Vomiting of Pregnancy
Objective The objective of this study was to observe the efficacy of antiemetic therapy (no emesis/retching episodes and no… Expand
  • table 1
  • table 2
  • table 3
Review
2015
Review
2015
State of the Art Antiemetic Therapy for Cancer Patients
Nausea and vomiting are common in cancer patients. The most common cause of nausea and vomiting is the administration of… Expand
2014
2014
Granisetron Transdermal System Improves Refractory Nausea and Vomiting in Gastroparesis
BackgroundSymptoms of gastroparesis include nausea and vomiting, which can markedly diminish quality of life. Nausea and vomiting… Expand
  • table 1
  • figure 1
2014
2014
Mo1284 Impaired Gastric Fundic Accommodation in Gastroparesis: Relationship to Gastroparesis Cardinal Symptom Index (GCSI) Severity Scores
24) of gastroparesis patients with refractory symptoms of nausea and vomiting. Interestingly, not only nausea and vomiting… Expand
2013
2013
Mo2069 Granisetron Transdermal Patch for Treatment of Nausea and Vomiting in Gastroparesis: Response to Treatment Using the Clinical Patient Grading Assessment Scale (CPGAS)
 
Review
2012
Review
2012
Granisetron Transdermal Patch for Treatment of Nausea in Patients Undergoing Cisplatin Based Chemotherapy for Cervical Cancer
Objective: The purpose of this study was to define the incidence of chemotherapy-induced nausea and vomiting (CINV) in newly… Expand
  • table 1
2009
2009
Emetogenicity of multiday chemotherapy regimens: Drug and patient factors affecting control of CINV.
  • J. Howell, H. Brown
  • Journal of clinical oncology : official journal…
  • 2009
    • Corpus ID: 43717774
e20683 Background: Multi-day chemo regimens have particular advantages in increasing tolerability and maintaining dose intensity… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE